Towards controlling severe asthma

Oral Presentation
Chairs: E. Bel (Amsterdam, The Netherlands), L. Allegra (Milano, Italy)

Methotrexate in treatment of severe difficult-to-treat asthma: randomized, double-blind, placebo-controlled study A. Obojski, B. Chmielowicz, R. Dobek, A. Bielous-Wilk, W. Krzysztof, W. Barg, B. Panaszek (Wroclaw, Poland)
Antinuclear antibodies and severe evolution of asthma I. Agache, L. Duca, M. Anghel, G. Pamfil (Brasov, Romania)
Safety of formoterol in asthma trials M. Sears, A. Ottosson, F. Radner, S. Suissa (Hamilton, ON, Montreal, QC, Canada; Lund, Sweden)
Does adherence to the British Thoracic Society (BTS) asthma guidelines prevent readmission within the first month S. Agarwal, B. McDonough, S. Thompson, J. Hadcroft (Liverpool, United Kingdom)
The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics D. Pinot, A. Nieves, A. M. Lorec, D. P. Breen, M. Badier, D. Vervloet, A. Magnan (Marseille, France)
Has asthma control improved since AIRE? Results of a survey in 5 European countries J. L. Desfougeres, B. Sohier, D. Freedman, K. Annunziata, A. Lemoine, M. Poterre (Marly le Roi, France; Princeton, NJ, United States Of America)
Perception of asthma control by patients: results of a survey in 5 European countries J. L. Desfougeres, B. Sohier, D. Freedman, K. Annunziata, A. Lemoine, M. Poterre (Marly le Roi, France; Princeton, NJ, United States Of America)